Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting, 52326 [2015-21291]
Download as PDF
<![CDATA[
52326
Federal Register / Vol. 80, No. 167 / Friday, August 28, 2015 / Notices
participating hospitals will be screened
and enrolled. There will be a one-time
computer-administered interview, and
patients will also be asked to provide a
one-time blood and buccal cell mouth
wash sample and lymphoma cases will
organochlorines, trichloroethylene, and
benzene) and genetic susceptibility.
Other factors potentially related to
lymphoma, such as viral infections,
ultraviolet radiation exposure, medical
conditions, and other lifestyle factors
will also be studied. Patients from 11
be asked to make available a portion of
their pathology sample.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
3,086.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Frequency of
response
Time per
response
(hours)
Annual burden
hours
Types of respondents
Instrument
Potential Study Subjects
Consented Patient
Cases.
Consented Patient Controls.
Study Pathologists .........
Interviewers ...................
Screening Questions ...........................................
Core Questionnaire & Occupational Job Module
1,804
967
1
1
5/60
105/60
150
1,692
Core Questionnaire & Occupational Job Module
300
1
105/60
525
Pathology sample request and tracking form .....
Tracking forms .....................................................
10
15
97
85
5/60
30/60
81
638
Dated: August 24, 2015.
Karla Bailey,
Project Clearance Liaison, National Cancer
Institute, NIH.
[FR Doc. 2015–21273 Filed 8–27–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Diabetes Mellitus Interagency
Coordinating Committee Meeting
The Diabetes Mellitus
Interagency Coordinating Committee
(DMICC) will hold a meeting on
September 28, 2015. The topic for this
meeting will be ‘‘New Opportunities for
Clinical Research on Type 2 Diabetes.’’
The meeting is open to the public.
DATES: The meeting will be held on
September 28, 2015 from 1:00 p.m. to
4:30 p.m. Individuals wanting to present
oral comments must notify the contact
person at least 10 days before the
meeting date.
ADDRESSES: The meeting will be held in
the Democracy 2 Building at 6707
Democracy Blvd., Bethesda, MD, in
Conference Room 701.
FOR FURTHER INFORMATION CONTACT: For
further information concerning this
meeting, see the DMICC Web site,
www.diabetescommittee.gov, or contact
Dr. B. Tibor Roberts, Executive
Secretary of the Diabetes Mellitus
Interagency Coordinating Committee,
National Institute of Diabetes and
Digestive and Kidney Diseases, 31
Center Drive, Building 31A, Room
9A19, MSC 2560, Bethesda, MD 20892–
2560, telephone: 301–496–6623; FAX:
301–480–6741; email: dmicc@
mail.nih.gov.
Lhorne on DSK5TPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
14:19 Aug 27, 2015
Jkt 235001
The
DMICC, chaired by the National
Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK) comprising
members of the Department of Health
and Human Services and other federal
agencies that support diabetes-related
activities, facilitates cooperation,
communication, and collaboration on
diabetes among government entities.
DMICC meetings, held several times a
year, provide an opportunity for
Committee members to learn about and
discuss current and future diabetes
programs in DMICC member
organizations and to identify
opportunities for collaboration. The
September 28, 2015 DMICC meeting
will focus on New Opportunities for
Clinical Research on Type 2 Diabetes.
Any member of the public interested
in presenting oral comments to the
Committee should notify the contact
person listed on this notice at least 10
days in advance of the meeting.
Interested individuals and
representatives or organizations should
submit a letter of intent, a brief
description of the organization
represented, and a written copy of their
oral presentation in advance of the
meeting. Only one representative of an
organization will be allowed to present;
oral comments and presentations will be
limited to a maximum of 5 minutes.
Printed and electronic copies are
requested for the record. In addition,
any interested person may file written
comments with the Committee by
forwarding their statement to the
contact person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Because of time constraints for the
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
meeting, oral comments will be allowed
on a first-come, first-serve basis.
Members of the public who would
like to receive email notification about
future DMICC meetings should register
for the listserv available on the DMICC
Web site, www.diabetescommittee.gov.
Dated: August 21, 2015.
B. Tibor Roberts,
Executive Secretary, DMICC, Office of
Scientific Program and Policy Analysis,
National Institute of Diabetes and Digestive
and Kidney Diseases, National Institutes of
Health.
[FR Doc. 2015–21291 Filed 8–27–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
E:\FR\FM\28AUN1.SGM
28AUN1
]]>Agencies
[Federal Register Volume 80, Number 167 (Friday, August 28, 2015)]
[Notices]
[Page 52326]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-21291]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Diabetes Mellitus Interagency Coordinating Committee
Meeting
SUMMARY: The Diabetes Mellitus Interagency Coordinating Committee
(DMICC) will hold a meeting on September 28, 2015. The topic for this
meeting will be ``New Opportunities for Clinical Research on Type 2
Diabetes.'' The meeting is open to the public.
DATES: The meeting will be held on September 28, 2015 from 1:00 p.m. to
4:30 p.m. Individuals wanting to present oral comments must notify the
contact person at least 10 days before the meeting date.
ADDRESSES: The meeting will be held in the Democracy 2 Building at 6707
Democracy Blvd., Bethesda, MD, in Conference Room 701.
FOR FURTHER INFORMATION CONTACT: For further information concerning
this meeting, see the DMICC Web site, www.diabetescommittee.gov, or
contact Dr. B. Tibor Roberts, Executive Secretary of the Diabetes
Mellitus Interagency Coordinating Committee, National Institute of
Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building
31A, Room 9A19, MSC 2560, Bethesda, MD 20892-2560, telephone: 301-496-
6623; FAX: 301-480-6741; email: dmicc@mail.nih.gov.
SUPPLEMENTARY INFORMATION: The DMICC, chaired by the National Institute
of Diabetes and Digestive and Kidney Diseases (NIDDK) comprising
members of the Department of Health and Human Services and other
federal agencies that support diabetes-related activities, facilitates
cooperation, communication, and collaboration on diabetes among
government entities. DMICC meetings, held several times a year, provide
an opportunity for Committee members to learn about and discuss current
and future diabetes programs in DMICC member organizations and to
identify opportunities for collaboration. The September 28, 2015 DMICC
meeting will focus on New Opportunities for Clinical Research on Type 2
Diabetes.
Any member of the public interested in presenting oral comments to
the Committee should notify the contact person listed on this notice at
least 10 days in advance of the meeting. Interested individuals and
representatives or organizations should submit a letter of intent, a
brief description of the organization represented, and a written copy
of their oral presentation in advance of the meeting. Only one
representative of an organization will be allowed to present; oral
comments and presentations will be limited to a maximum of 5 minutes.
Printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
Committee by forwarding their statement to the contact person listed on
this notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person. Because of time constraints for the meeting,
oral comments will be allowed on a first-come, first-serve basis.
Members of the public who would like to receive email notification
about future DMICC meetings should register for the listserv available
on the DMICC Web site, www.diabetescommittee.gov.
Dated: August 21, 2015.
B. Tibor Roberts,
Executive Secretary, DMICC, Office of Scientific Program and Policy
Analysis, National Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health.
[FR Doc. 2015-21291 Filed 8-27-15; 8:45 am]
BILLING CODE 4140-01-P
